In the MC38-EGFR5 tumor model, αPD1-mIL12mut2 treatment also suppressed tumor growth more effectively than the combination therapy of αEGFR-mIL12mut2 and αPD-1 (Fig. 4c). This evidence concerns the gene CLEC14A and neoplasm.